PUBLISHER: The Business Research Company | PRODUCT CODE: 1948603
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948603
A vaginal pessary is a device, typically made from silicone or plastic, that is inserted into the vagina to support pelvic organs such as the bladder, uterus, or rectum. It is used to manage conditions such as pelvic organ prolapse and stress urinary incontinence by repositioning weakened tissues. This offers a non-surgical treatment option for women seeking relief, particularly those who are either unable or unwilling to undergo surgery.
The main vaginal pessary products include the vaginal ring, Gehrung, cube, Gellhorn, and others. A vaginal ring is a flexible, ring-shaped device inserted into the vagina to provide support for pelvic organ prolapse or to manage urinary incontinence. It is made from materials such as elastomer, polyethylene, silicone, polypropylene, and latex and is used for uterine prolapse, urinary incontinence, pediatric urogynecology, and fistula repair. These products are used in hospitals, ambulatory surgical centers, clinics, and other healthcare settings.
Tariffs are impacting the vaginal pessary market by increasing costs of imported silicone, polymers, medical-grade plastics, and precision molding equipment used in device manufacturing. Healthcare providers and manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces pricing pressure on exports. These tariffs are increasing device costs and influencing procurement decisions. However, they are also encouraging domestic production, regional material sourcing, and innovation in cost-effective pessary designs.
The vaginal pessary market research report is one of a series of new reports from The Business Research Company that provides vaginal pessary market statistics, including vaginal pessary industry global market size, regional shares, competitors with a vaginal pessary market share, detailed vaginal pessary market segments, market trends and opportunities, and any further data you may need to thrive in the vaginal pessary industry. This vaginal pessary market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vaginal pessary market size has grown strongly in recent years. It will grow from $0.42 billion in 2025 to $0.46 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing prevalence of pelvic organ prolapse, rising awareness of conservative treatment options, expansion of gynecological care services, availability of improved medical-grade materials, increased diagnosis rates in women's health.
The vaginal pessary market size is expected to see strong growth in the next few years. It will grow to $0.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for non-invasive urogynecological treatments, rising aging female population, expansion of outpatient gynecology services, growing focus on quality-of-life treatments, increasing adoption in emerging healthcare markets. Major trends in the forecast period include increasing adoption of silicone-based pessaries, rising preference for non-surgical treatment options, growing demand for customized pessary designs, expansion of long-term pelvic support devices, enhanced focus on patient comfort and safety.
The growing adoption of telemedicine is expected to drive the expansion of the vaginal pessary market in the coming years. Telemedicine involves the remote diagnosis, consultation, and treatment of patients using telecommunications technologies such as video calls, mobile applications, and online platforms. Its growth is fueled by the increasing demand for convenient and accessible healthcare, enabling remote consultations that save time, reduce hospital visits, and improve care in rural and underserved areas. Telemedicine facilitates vaginal pessary use by providing remote access to education, follow-up care, and guidance for fitting, discomfort management, and maintenance, thereby enhancing patient adherence and treatment outcomes. For example, in October 2025, ScienceSoft USA Corporation, a U.S.-based data management firm, reported that by the end of 2026, telemedicine is expected to account for approximately 25-30% of all medical visits in the United States. Consequently, the rising adoption of telemedicine is poised to boost the vaginal pessary market.
Leading companies in the vaginal pessary market are focusing on developing advanced products, such as personalized pessary solutions, to enhance comfort and treatment outcomes for women with pelvic floor disorders. Personalized pessaries are custom-made devices designed to fit an individual's anatomy, providing optimal support for pelvic floor disorders. For instance, in March 2024, Cosm Medical, a Canada-based medical device company, received U.S. Food and Drug Administration (FDA) approval for its personalized Gynethotics Pessaries. Gynethotics uses advanced technologies, including AI and 3D printing, to create patient-specific pessaries with nearly 10 million possible configurations, far exceeding the 100 options of standard devices. Made from silicone with adjustable material stiffness, these pessaries offer a precise fit and greater comfort. Unlike the traditional trial-and-error fitting method, Gynethotics relies on advanced measurements and clinical assessments for personalization, improving effectiveness and boosting patient satisfaction.
In September 2024, ConTIPI Medical Ltd., an Israel-based provider of vaginal pessary products, teamed up with EVERSANA to launch the ProVate device in the U.S., targeting women with pelvic organ prolapse. The ProVate device is a minimally invasive, self-inserted solution designed for easy management at home, reducing the need for frequent clinic visits. By partnering with EVERSANA, a U.S.-based healthcare services company, the collaboration aims to improve access to this innovative treatment, empowering patients with greater autonomy and enhancing their overall quality of life.
Major companies operating in the vaginal pessary market are Medline Industries LP, CooperSurgical Inc., Bliss GVS Pharma, AMI Polymer Pvt. Ltd., MedGyn Products Inc., Kolplast, Indosurgicals Pvt Ltd., Advance Rubber Industries, Endotherapeutics Pty Ltd., Grayline Medical, Fem Therapeutics Inc., Proexamine Surgicals Pvt Ltd., Naulakha Industries, Wallach Surgical Devices, For.me.sa., Reyansh Remedies, Panpac Medical Corp., Milex Products Inc., Gyneas A/S, Medesign A/S
North America was the largest region in the vaginal pessary market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaginal pessary market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the vaginal pessary market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vaginal pessary market consists of sales of incontinence pessaries, pelvic floor training devices, pessary insertion and removal tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vaginal Pessary Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses vaginal pessary market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vaginal pessary ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vaginal pessary market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.